🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America

Recruitingn/aAges 18 Years - anyAllUniversity of Alabama at Birmingham
NCT07262320 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is an international, multicenter, observational study aimed at investigating acute kidney injury requiring renal replacement therapy (AKI-RRT) in Latin American countries. The main questions this study aims to answer are: * What is the epidemiology, outcomes, and processes of care for patients with AKI-RRT in Latin America? * How do outcomes differ across different countries in Latin America? * What factors (demographics, clinical, socioeconomic) influence outcomes in patients with AKI-RRT in Latin America? The main aims of this study are to: * Establish a comprehensive database containing clinical, laboratory, treatment, process, and outcome data of patients with AKI-RRT in Latin America * Describe current epidemiology of AKI-RRT in Latin America * Compare processes of care and outcomes across different countries in Latin America * Provide data resources to facilitate and promot

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patient (≥18) admitted to the ICU * First ICU admission during current hospitalization * Diagnosis of acute kidney injury stage 3 according to KDIGO guidelines * RRT initiated no earlier than 3 days before or no later than 7 days after ICU admission Exclusion Criteria: * Transfer from outside hospital with ongoing RRT * RRT exposure of less than 2 days (if CRRT or PD was provided) or less than 2 HD/SLED sessions * Kidney failure (ESRD) patients on maintenance dialysis * Kidney transplant recipients * Previous or new diagnosis of glomerulonephritis
💊

What it tests

  • Not listed
📍

Where

15 sites
Hospital Obrero No 2
Cochabamba, Bolivia
Ana Nery Hospital
Bahia, Brazil
Hospital Sao Lucas da PUCRS
Porto Alegre, Brazil
Hospital das Clínicas da Universidade de São Paulo
São Paulo, Brazil
Hospital Las Higueras
Talcahuano, Chile
Fundación Cardioinfantil
Bogotá, Colombia
Hospital San Jose de Popayan
Popayán, Colombia
Hospital General de la Plaza de la Salud
Santo Domingo, Dominican Republic

…and 7 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy